Peter is the lead research assistant on Dr. Sigmon’s Interim Buprenorphine Treatment clinical trials, investigating technology-assisted medication delivery to reduce illicit opioid use and other risk behaviors. His prior experience includes working with adults to address substance abuse and mental health needs, providing supportive housing assistance to those experiencing chronic homelessness, and working with traumatic brain injury survivors to address life skills needs. Peter obtained a Bachelor of Arts in Psychology at UVM in 2012.
Peter Lontine, BA
